Lee's Pharmaceutical Holdings Limited
LPCUF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$112.06M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $112.06 Million |
|---|---|
| Enterprise Value | $-2,464,012.00 |
| Annual dividend | $0.01 |
| Dividend yield | 5.63% |
| Earnings per Share | $0.16 |
| Beta | 0.6 |
| Outstanding Shares | 588,835,000 |
Return
| Return on Equity | 8.45% |
|---|---|
| Return on Assets | 5.16% |
| Return on Invested Capital | -0.46% |
Valuation & Multiples
| P/E Ratio | 3.64 |
|---|---|
| PEG | 2 |
| Price to Sales | 0.06 |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | 0.21 |
| Enterprise Value to EBIT | -45.26 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 30, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Lee's Pharmaceutical Holdings Limited
1,094 employees
CEO: Wanee Leelalertsuphakun
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease are...